Skip to content

Clinical trials

Observational Syphilis trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Syphilis Phase: Observational Clear all

37 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20071
20081
20092
20113
20121
20142
20162
20172
20181
20193
20202
20212
20221
20231
20241
20256
20264

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed17
Recruiting6
Unknown status6
Not yet recruiting3
Active, not recruiting2
Terminated2
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
London School of Hygiene and Tropical Medicine2
National Institute of Allergy and Infectious Diseases (NIAID)2
University of North Carolina, Chapel Hill2
University of Zimbabwe2
ANRS, Emerging Infectious Diseases1
American Laboratory Products Company1
Azienda Ospedaliera SS. Antonio e Biagio e Cesare Arrigo di Alessandria1
Chembio Diagnostic Systems, Inc.1
Chinese Academy of Medical Sciences1
Gardiens de Vies1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Syphilis37
HIV Infections10
Sexually Transmitted Diseases10
Gonorrhea7
Acquired Immunodeficiency Syndrome6
Chlamydia Infections6
Hepatitis B4
Hepatitis C3
COVID-192
Giardiasis2

Trials

Showing 76 to 37 of 37. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.